Literature DB >> 19373586

beta-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces.

Mehdi Haghi1, Shohre Khorshidi, Mohammad Ali Hosseinpour Feizi, Nasser Pouladi, Abbas A Hosseinpour Feizi.   

Abstract

The aim of this study was to investigate the prevalence and spectrum of beta-thalassemia (beta-thal) mutations in the population of Sunni Muslim Kurds in western Iran and to set up a prenatal diagnostic laboratory. Sixty unrelated Kurdish beta-thal patients identified in hematology clinics from different cities were studied. The mutations in 120 chromosomes were studied by polymerase chain reaction-amplification refractory mutation system and direct sequencing methods. We found fifteen beta-thal mutations, and IVS-II-1 (G>A) was the most frequent, comprising 35% of all mutations. Other common mutations were frameshift codons 8/9 (+G) 15.7%, IVS-I-1 (G>A) 8%, FSC 5 (-CT) 6.7%, FSC 8 (-AA) 6.7%, and IVS-I-110 (G>A) 6%. This is the first comprehensive study in this region and could provide a reference for prenatal testing and genetic counseling in this population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373586     DOI: 10.1080/03630260902862020

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

1.  β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq.

Authors:  Nasir A S Al-Allawi; Kawa M A Hassan; Anwar K Sheikha; Farida F Nerweiy; Raji S Dawood; Jaladet Jubrael
Journal:  Mol Biol Int       Date:  2010-07-05

Review 2.  Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.

Authors:  Nasir Al-Allawi; Sarah Al Allawi; Sana D Jalal
Journal:  J Community Genet       Date:  2020-11-22

Review 3.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

4.  Detection of Rare Beta Globin Gene Mutation [+22 5UTR(G>A)] in an Infant, Despite Prenatal Screening.

Authors:  Mohammad Reza Mahdavi; Hosein Karami; Mohammad Taghi Akbari; Hosein Jalali; Payam Roshan
Journal:  Case Rep Hematol       Date:  2013-04-14

Review 5.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01

6.  Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.

Authors:  Shaema Salih Amin; Sana Dlawar Jalal; Kosar Muhammed Ali; Ali Ibrahim Mohammed; Luqman Khalid Rasool; Tara Jamel Osman
Journal:  Biomed Res Int       Date:  2020-02-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.